Safety of EstroG-100TM as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

doi:10.2903/j.efsa.2016.4589

Safety of EstroG-100^TM as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

Institut for Idræt og Ernæring - Fedmeforskning

53 Downloads (Pure)

Abstract

Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on EstroG-100^TM as a novel food (NF) submitted pursuant to Regulation (EC) No 258/97 of the European Parliament and of the Council. The NF is EstroG-100^TM, a hot-water extract of a mixture of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai), which is concentrated and spray-dried. The information provided on the composition, specifications and stability of the NF is sufficient, and does not raise safety concerns. The applicant intends to use EstroG-100^TM in food supplements, with a proposed maximum intake level of 514 mg/day. The target population is post-menopausal women. The Panel considers that the information provided does not raise safety concerns as regards the genotoxicity of the NF. The Panel considers that the no-observed-adverse effect level (NOAEL) derived from the subchronic 90-day oral toxicity study with EstroG-100^TM, which was supported by observations in other studies, is 500 mg/kg body weight (bw) per day. Taking into account the NOAEL and the proposed maximum intake level, the Panel considers that the margin of safety of 68 is not sufficient. Based on the absence of chronic toxicity data, increase in effects with exposure duration in toxicity
studies, and the absence of investigations of liver parameters and haematology in human studies, the Panel applies the uncertainty factor of 200 to derive the maximum safe intake level for the NF. Thus, the Panel concludes that the NF, EstroG-100^TM, is safe for the use in food supplements at the maximum intake level of 175 mg/day for an adult of 70 kg bw.

Originalsprog	Engelsk
Artikelnummer	4589
Tidsskrift	E F S A Journal
Vol/bind	14
Udgave nummer	10
Antal sider	20
ISSN	1831-4732
DOI	https://doi.org/10.2903/j.efsa.2016.4589
Status	Udgivet - 24 okt. 2016

Emneord

Det Natur- og Biovidenskabelige Fakultet

Adgang til dokumentet

10.2903/j.efsa.2016.4589Licens: CC BY

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (Sjodin)_EFSA Journal_2016_Vol 14(10)_4589Forlagets udgivne version, 1,2 MBLicens: CC BY

Citationsformater

@article{176136724ed84c0faef5b29a430a5476,

title = "Safety of EstroG-100TM as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)",

abstract = "Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on EstroG-100TM as a novel food (NF) submitted pursuant to Regulation (EC) No 258/97 of the European Parliament and of the Council. The NF is EstroG-100TM, a hot-water extract of a mixture of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai), which is concentrated and spray-dried. The information provided on the composition, specifications and stability of the NF is sufficient, and does not raise safety concerns. The applicant intends to use EstroG-100TM in food supplements, with a proposed maximum intake level of 514 mg/day. The target population is post-menopausal women. The Panel considers that the information provided does not raise safety concerns as regards the genotoxicity of the NF. The Panel considers that the no-observed-adverse effect level (NOAEL) derived from the subchronic 90-day oral toxicity study with EstroG-100TM, which was supported by observations in other studies, is 500 mg/kg body weight (bw) per day. Taking into account the NOAEL and the proposed maximum intake level, the Panel considers that the margin of safety of 68 is not sufficient. Based on the absence of chronic toxicity data, increase in effects with exposure duration in toxicitystudies, and the absence of investigations of liver parameters and haematology in human studies, the Panel applies the uncertainty factor of 200 to derive the maximum safe intake level for the NF. Thus, the Panel concludes that the NF, EstroG-100TM, is safe for the use in food supplements at the maximum intake level of 175 mg/day for an adult of 70 kg bw.",

keywords = "Faculty of Science, EstroG-100TM, Cynanchum wilfordii, Phlomis umbrosa, Angelica gigas, Novel food, Safety",

author = "Sj{\"o}din, {Anders Mikael} and {EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)}",

note = "EFSA 2016 4589",

year = "2016",

month = oct,

day = "24",

doi = "10.2903/j.efsa.2016.4589",

language = "English",

volume = "14",

journal = "E F S A Journal",

issn = "1831-4732",

publisher = "European Food Safety Authority (E F S A)",

number = "10",

}

TY - JOUR

T1 - Safety of EstroG-100TM as a novel food pursuant to Regulation (EC) No 258/97

T2 - (Scientific Opinion)

AU - Sjödin, Anders Mikael

AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

N1 - EFSA 2016 4589

PY - 2016/10/24

Y1 - 2016/10/24

N2 - Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on EstroG-100TM as a novel food (NF) submitted pursuant to Regulation (EC) No 258/97 of the European Parliament and of the Council. The NF is EstroG-100TM, a hot-water extract of a mixture of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai), which is concentrated and spray-dried. The information provided on the composition, specifications and stability of the NF is sufficient, and does not raise safety concerns. The applicant intends to use EstroG-100TM in food supplements, with a proposed maximum intake level of 514 mg/day. The target population is post-menopausal women. The Panel considers that the information provided does not raise safety concerns as regards the genotoxicity of the NF. The Panel considers that the no-observed-adverse effect level (NOAEL) derived from the subchronic 90-day oral toxicity study with EstroG-100TM, which was supported by observations in other studies, is 500 mg/kg body weight (bw) per day. Taking into account the NOAEL and the proposed maximum intake level, the Panel considers that the margin of safety of 68 is not sufficient. Based on the absence of chronic toxicity data, increase in effects with exposure duration in toxicitystudies, and the absence of investigations of liver parameters and haematology in human studies, the Panel applies the uncertainty factor of 200 to derive the maximum safe intake level for the NF. Thus, the Panel concludes that the NF, EstroG-100TM, is safe for the use in food supplements at the maximum intake level of 175 mg/day for an adult of 70 kg bw.

AB - Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on EstroG-100TM as a novel food (NF) submitted pursuant to Regulation (EC) No 258/97 of the European Parliament and of the Council. The NF is EstroG-100TM, a hot-water extract of a mixture of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai), which is concentrated and spray-dried. The information provided on the composition, specifications and stability of the NF is sufficient, and does not raise safety concerns. The applicant intends to use EstroG-100TM in food supplements, with a proposed maximum intake level of 514 mg/day. The target population is post-menopausal women. The Panel considers that the information provided does not raise safety concerns as regards the genotoxicity of the NF. The Panel considers that the no-observed-adverse effect level (NOAEL) derived from the subchronic 90-day oral toxicity study with EstroG-100TM, which was supported by observations in other studies, is 500 mg/kg body weight (bw) per day. Taking into account the NOAEL and the proposed maximum intake level, the Panel considers that the margin of safety of 68 is not sufficient. Based on the absence of chronic toxicity data, increase in effects with exposure duration in toxicitystudies, and the absence of investigations of liver parameters and haematology in human studies, the Panel applies the uncertainty factor of 200 to derive the maximum safe intake level for the NF. Thus, the Panel concludes that the NF, EstroG-100TM, is safe for the use in food supplements at the maximum intake level of 175 mg/day for an adult of 70 kg bw.

KW - Faculty of Science

KW - EstroG-100TM

KW - Cynanchum wilfordii

KW - Phlomis umbrosa

KW - Angelica gigas

KW - Novel food

KW - Safety

U2 - 10.2903/j.efsa.2016.4589

DO - 10.2903/j.efsa.2016.4589

M3 - Journal article

SN - 1831-4732

VL - 14

JO - E F S A Journal

JF - E F S A Journal

IS - 10

M1 - 4589

ER -